Proposed Reverse Takeover Nov. 28, 2018

Vanity has announced entering a binding letter of intent dated November 27, 2018 with a proposed reverse takeover of the company by Akseera Pharma Corp. The resulting issuer will operate as a life sciences issuer continuing the business of Akseera. The proposed transaction is subject to the approval of the TSX Venture Exchange. The stock was halted pending news by the company, and the halt will be lifted if and when obtaining Exchange approval.